A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

University of Pittsburgh MC /ID# 210839, Pittsburgh

DermAssociates /ID# 210838, Rockville

Medication Management, LLC /ID# 213217, Greensboro

Florida Academic Centers Research /ID# 210337, Coral Gables

Medallion Clinical Research Institute, LLC /ID# 210329, Naples

Renstar Medical Research /ID# 210878, Ocala

Somerset Skin Centre /ID# 211596, Troy

Great Lakes Research, Inc. /ID# 210192, Bay City

Froedtert Mem Lutheran Hosp /ID# 210194, Milwaukee

Central Dermatology, PC /ID# 210301, St Louis

Epiphany Dermatology /ID# 211493, Overland Park

Center for Clinical Studies /ID# 210362, Houston

Suzanne Bruce and Associates /ID# 212210, Houston

Center for Clinical Studies /ID# 211565, Cypress

Austin Institute for Clinical Research /ID# 212203, Pflugerville

Advanced Research Associates /ID# 210634, Glendale

Encino Research Center / T. Jo /ID# 211735, Encino

Bakersfield Derma & Skin Cance /ID# 210773, Bakersfield

UC Davis Health /ID# 210411, Sacramento

Oregon Medical Res Center PC /ID# 210334, Portland

Premier Clinical Research /ID# 212209, Spokane

Cognitive Clinical Trials /ID# 210770, Scottsdale

Burke Pharmaceutical Research /ID# 211386, Hot Springs

Tien Q Nguyen MD, Inc /ID# 210775, Fountain Valley

Dermatology Physicians of CT /ID# 210637, Shelton

AllCutis Research Inc /ID# 211429, Portsmouth